Target type: molecularfunction
Combining with neuropeptide Y to initiate a change in cell activity. [PMID:9315606]
Neuropeptide Y receptors (NPYR) are G protein-coupled receptors (GPCRs) that mediate the biological effects of the neuropeptide Y (NPY) family of peptides. NPY is a highly conserved peptide that plays a wide range of physiological roles, including the regulation of appetite, stress response, anxiety, and blood pressure. NPYRs are expressed in various tissues and organs, including the brain, heart, liver, and adipose tissue. There are five known NPYR subtypes: Y1, Y2, Y4, Y5, and Y6, each exhibiting distinct pharmacological and functional properties. The molecular function of NPYR activity involves the following steps: 1. Binding of NPY to its receptor: NPY binds to the extracellular domain of the NPYR, triggering a conformational change in the receptor. 2. Activation of G protein: The conformational change in the receptor activates a heterotrimeric G protein, typically a Gαi/o protein. 3. Signaling cascade: The activated Gαi/o protein dissociates from the βγ subunits and interacts with downstream signaling molecules, such as adenylyl cyclase or phospholipase C. 4. Production of second messengers: The activated signaling molecules generate second messengers, such as cyclic AMP (cAMP) or inositol trisphosphate (IP3). 5. Cellular response: The second messengers trigger a variety of cellular responses, including changes in gene expression, ion channel activity, and enzyme activity. The specific cellular response depends on the NPYR subtype, cell type, and other factors. For example, activation of Y1 receptors typically inhibits adenylyl cyclase activity, leading to a decrease in cAMP levels and inhibition of neuronal firing. Y2 receptors, on the other hand, are known to couple to Gαi/o proteins and inhibit adenylyl cyclase and activate phospholipase C. This leads to a reduction in cAMP levels and an increase in IP3 levels, respectively. The activation of Y4 receptors, which are primarily expressed in the central nervous system, has been shown to reduce food intake and body weight. Y5 receptors are involved in the regulation of feeding behavior and have been implicated in obesity. Finally, Y6 receptors, which are mainly found in the periphery, play a role in the regulation of smooth muscle contraction. In summary, NPYR activity involves a complex cascade of events that ultimately leads to a wide range of physiological responses. Understanding the molecular function of these receptors is crucial for developing novel therapeutic strategies for a variety of disorders, including obesity, anxiety, and cardiovascular diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Pyroglutamylated RF-amide peptide receptor | A pyroglutamylated RF-amide peptide receptor that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q96P65] | Homo sapiens (human) |
Neuropeptide Y receptor type 5 | A neuropeptide Y receptor type 5 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q15761] | Homo sapiens (human) |
Neuropeptide Y receptor type 2 | A neuropeptide Y receptor type 2 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P49146] | Homo sapiens (human) |
Neuropeptide Y receptor type 1 | A neuropeptide Y receptor type 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P25929] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
benextramine | benextramine: RN given refers to parent cpd | ||
econazole | 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole : A member of the class of imidazoles that is 1-(2,4-dichlorophenyl)-2-(imidazol-1-yl)ethanol in which the hydroxyl hydrogen is replaced by a 4-chlorobenzyl group. econazole : A racemate composed of equimolar amounts of (R)- and (S)-econazole. Used (as its nitrate salt) to treat skin infections such as athlete's foot, jock itch, ringworm and other fungal skin infections. Econazole: An imidazole derivative that is commonly used as a topical antifungal agent. | dichlorobenzene; ether; imidazoles; monochlorobenzenes | |
2-(4,6,7-Trimethyl-2-quinazolinyl)guanidine | quinazolines | ||
N-(4-ethoxyphenyl)-4-[hydroxy(diphenyl)methyl]-1-piperidinecarbothioamide | diarylmethane | ||
2-(2-methoxyphenyl)-N-[4-[5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide | oxadiazole; ring assembly | ||
3,5-dimethyl-4-[(4-methylphenyl)sulfonyl-phenylmethyl]isoxazole | sulfonic acid derivative | ||
bibp 3226 | BIBP 3226: a selective non-peptide neuropeptide Y Y1 receptor antagonist; structure given in first source; BIBP-3435 is the S-enantiomer | ||
cgp 71683 a | naphthalenes; sulfonic acid derivative | ||
n-(4-((4-(dimethylamino)quinazolin-2-yl)amino)cyclohexyl)-3,4-difluorobenzamide hydrochloride | |||
4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl)-piperidine hydrogen chloride | |||
bms 193885 | |||
jnj-5207787 | N-(1-Acetyl-2,3-dihydro-1H-indol-6-yl)-3-(3-cyano-phenyl)-N-(1-(2-cyclopentyl-ethyl)-piperidin-4yl)acrylamide: structure in first source | ||
mk-0557 | |||
neuropeptide y (24-36) amide, n-acetyl-(leu(28,31))- | neuropeptide Y (24-36) amide, N-acetyl-(Leu(28,31))-: a presynaptic (Y2) receptor-specific neuropeptide Y analog | ||
neuropeptide y | Neuropeptide Y: A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. | ||
bombesin | |||
lu aa33810 | |||
jnj-31020028 | |||
nitd 609 | NITD 609: an antimalarial and coccidiostat; structure in first source |